The Japanese pharmaceutical company DAIICHI SANKYO Group has purchased the European rights to the osteoporosis medication EVISTA® from the U.S. Company Eli Lilly and Company. In the process, the comp
read more » Discuss Add this link to...Bury Add to:
| Bookmarks
At the beginning of August, DAIICHI SANKYO DEUTSCHLAND GmbH is planning to take over most of the sales force for primary-care physicians in Germany used by Merck Pharma GmbH and to integrate them int
read more » Discuss Add this link to...Bury Add to:
| Bookmarks